Cerebral ischemic stroke is one of the most common causes of adult death or disability, accounting for 1 in 17 deaths in the United States alone.1 Currently, the only approved drug treatment for ischemic stroke is tissue plasminogen activator (tPA), which is only effective for a subset of stroke patients and must be administered within the first few hours to be effective. Here, PLAT is linked to Stroke.